Patents Assigned to ReQualia Pharma Inc.
  • Crystal forms of an imidazole derivative
    Patent number: 7960407
    Abstract: The invention relates to the essentially pure ?/-[({2-[4-(2-Ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenyl]ethyl}amino)carbonyl]-4-methylbenzenesulfonamide Polymorph Forms A and B and to processes for the preparation of, compositions containing and to the uses of, such crystal forms.
    Type: Grant
    Filed: March 1, 2006
    Date of Patent: June 14, 2011
    Assignee: Requalia Pharma Inc.
    Inventors: Naoaki Haruta, Tomoki Kato, Zheng Jane Li, Toyoharu Numata, Andrew Vincent Trask
  • Substituted methyl aryl or heteroaryl amide compounds
    Patent number: 7534914
    Abstract: This invention provides a compound of the formula (I): wherein X represents a carbon atom or the like: Y represents imino, or the like: R1 represents an alkyl group having from 1 to 6 carbon atoms or the like: R2 and R3 independently represents a hydrogen atom or the like. These compounds are useful for the treatment of disease conditions mediated by prostaglandin such as pain, or the like in mammalian. This invention also provides a pharmaceutical composition comprising the above compound.
    Type: Grant
    Filed: April 29, 2005
    Date of Patent: May 19, 2009
    Assignee: ReQualia Pharma Inc.
    Inventors: Hiroki Koike, Kana Kon-i, Yukari Matsumoto, Kazunari Nakao, Yoshiyuki Okumura, Tatsuya Yamagishi